Document is current
Any future updates will be listed below
-
Authors
Xie, Linhui
Raj, Yash
Tong, Mingzhao
Nho, Kwangsik
Salama, Paul
Saykin, Andrew J.
Fang, Shiaofen
Yan, Jingwen
-
Funding
Funding for this research was provided by:
National Institutes of Health (U19 AG074879, U01 AG068057, R21 AG072101)
National Science Foundation (1942394)
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 1 August 2025
First Online: 18 August 2025
Declarations
:
: Dr. Saykin has received support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (in kind contribution of PET tracer precursor) and holds advisory roles with Siemens Medical Solutions USA, Inc., NIH NHLBI, and Eisai. His editorial commitments include serving as Editor-in-Chief for the journal “Brain Imaging and Behavior”, and he participates in various NIH/NIA advisory committees. All the remaining authors declare no conflict of interest.
